Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 35-5700 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Anti-Thymidine Phosphorylase Monoclonal Antibody (PGF-44C)
- Antibody type
- Monoclonal
- Antigen
- Other
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- PGF-44C
- Vial size
- 100 µg
- Concentration
- 0.5 mg/ml
- Storage
- -20°C
Submitted references Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.
Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.
Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C
Disease markers 2011;31(2):55-65
Disease markers 2011;31(2):55-65
Thymidylate synthase and thymidine phosphorylase as predictive markers of capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer.
Lee SJ, Choi YL, Park YH, Kim ST, Cho EY, Ahn JS, Im YH
Cancer chemotherapy and pharmacology 2011 Sep;68(3):743-51
Cancer chemotherapy and pharmacology 2011 Sep;68(3):743-51
Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis.
Chihara Y, Fujimoto K, Miyake M, Hiasa Y, Hirao Y
Oncology reports 2009 Jul;22(1):23-8
Oncology reports 2009 Jul;22(1):23-8
No comments: Submit comment
No validations: Submit validation data